WO2008102888A1 - 新規擬似糖脂質及びその用途 - Google Patents

新規擬似糖脂質及びその用途 Download PDF

Info

Publication number
WO2008102888A1
WO2008102888A1 PCT/JP2008/053105 JP2008053105W WO2008102888A1 WO 2008102888 A1 WO2008102888 A1 WO 2008102888A1 JP 2008053105 W JP2008053105 W JP 2008053105W WO 2008102888 A1 WO2008102888 A1 WO 2008102888A1
Authority
WO
WIPO (PCT)
Prior art keywords
novel
pseudoglycolipid
disclosed
formula
cancers
Prior art date
Application number
PCT/JP2008/053105
Other languages
English (en)
French (fr)
Inventor
Takuya Tashiro
Kenji Mori
Ken-Ichi Fuhshuku
Masaru Taniguchi
Ryusuke Nakagawa
Hiroshi Watarai
Original Assignee
Riken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken filed Critical Riken
Priority to EP08711869.1A priority Critical patent/EP2133326B1/en
Priority to ES08711869.1T priority patent/ES2561357T3/es
Priority to JP2009500256A priority patent/JP5504891B2/ja
Priority to US12/528,232 priority patent/US8299223B2/en
Publication of WO2008102888A1 publication Critical patent/WO2008102888A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

　本発明は、癌治療等に有効な新規擬似糖脂質及びその新規合成中間体、並びに該新規擬似糖脂質を含有する医薬等を提供する。 　下記一般式（１）で表される化合物又はその塩。 （式中、各記号の定義は明細書に記載の通りである。）
PCT/JP2008/053105 2007-02-22 2008-02-22 新規擬似糖脂質及びその用途 WO2008102888A1 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP08711869.1A EP2133326B1 (en) 2007-02-22 2008-02-22 Novel pseudoglycolipid and use thereof
ES08711869.1T ES2561357T3 (es) 2007-02-22 2008-02-22 Nuevo pseudoglucolípido y uso del mismo
JP2009500256A JP5504891B2 (ja) 2007-02-22 2008-02-22 新規擬似糖脂質及びその用途
US12/528,232 US8299223B2 (en) 2007-02-22 2008-02-22 Pseudoglycolipid and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007042873 2007-02-22
JP2007-042873 2007-02-22

Publications (1)

Publication Number Publication Date
WO2008102888A1 true WO2008102888A1 (ja) 2008-08-28

Family

ID=39710159

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053105 WO2008102888A1 (ja) 2007-02-22 2008-02-22 新規擬似糖脂質及びその用途

Country Status (5)

Country Link
US (1) US8299223B2 (ja)
EP (1) EP2133326B1 (ja)
JP (1) JP5504891B2 (ja)
ES (1) ES2561357T3 (ja)
WO (1) WO2008102888A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010030012A1 (ja) 2008-09-11 2010-03-18 独立行政法人理化学研究所 エステル化α－ガラクトシルセラミド類
EP2409966A1 (en) * 2009-03-20 2012-01-25 Consejo Superior de Investigaciones Científicas (CSIC) Aminocyclitol compounds, procedure for the obtainment and uses
WO2022102557A1 (ja) * 2020-11-12 2022-05-19 国立研究開発法人理化学研究所 擬似糖脂質誘導体並びにその合成中間体、製造方法及び用途
US11744860B2 (en) 2016-04-28 2023-09-05 Riken Technology for efficient activation of NKT cells

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2785683T3 (da) 2011-11-30 2020-04-14 Ludwig Inst For Cancer Res Ltd Inkt-cellemodulatorer og fremgangsmåder til anvendelse heraf

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10128250A1 (de) 2000-06-12 2001-12-20 Kotobuki Pharmaceutical Co Neue Glykolipidderivate
WO2003105769A2 (en) 2002-06-13 2003-12-24 New York University Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
US20050222048A1 (en) 2004-03-31 2005-10-06 The Research Foundation Of The City University Of New York Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
WO2007050668A1 (en) * 2005-10-25 2007-05-03 Ludwig Institute For Cancer Research Analogs of alpha galactosylceramide and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE421881T1 (de) * 1997-04-10 2009-02-15 Kyowa Hakko Kirin Co Ltd Nkt-zellenaktivatoren, die alpha-glycosylceramide enthalten
KR20080021761A (ko) * 2005-07-01 2008-03-07 국립 정신.신경센터 총장이 대표하는 일본국 당지질 유도체 및 이것을 유효 성분으로 하는 치료제

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10128250A1 (de) 2000-06-12 2001-12-20 Kotobuki Pharmaceutical Co Neue Glykolipidderivate
WO2003105769A2 (en) 2002-06-13 2003-12-24 New York University Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
US20050222048A1 (en) 2004-03-31 2005-10-06 The Research Foundation Of The City University Of New York Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
WO2007050668A1 (en) * 2005-10-25 2007-05-03 Ludwig Institute For Cancer Research Analogs of alpha galactosylceramide and uses thereof

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
ANGEW. CHEM. INT. ED. ENGL., vol. 43, 2004, pages 3818 - 3822
BIOCHIM. BIOPHYS. ACTA, 1973, pages 315 - 335
CARBOHYDRATE RESEARCH, vol. 329, 2000, pages 7 - 16
J. EXP. MED., vol. 198, 2003, pages 1631 - 1641
J. IMMUNOL., vol. 155, 1995, pages 2972 - 2983
J. IMMUNOL., vol. 161, 1998, pages 3271 - 3281
J. MED. CHEM., vol. 38, 1995, pages 2176 - 2187
NAT. IMMUNOL., vol. 4, 2003, pages 1164 - 1165
PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 5690 - 5693
SCIENCE, vol. 278, 1997, pages 1626 - 1629
See also references of EP2133326A4 *
TETRAHEDRON LETTERS, vol. 48, 2007, pages 3343 - 3347
TETRAHODRON LETTERS, vol. 48, 2007, pages 3343 - 3347
THE JOURNAL OF ORGANIC CHEMISTRY, vol. 69, 2004, pages 7694 - 7699
TSUNODA H. ET AL.: "Pseudo sugars, 34-Synthesis of 5a-carba-beta-D-glycosylceramide analogs linked by imino, ether and sulfide bridges", LIEBIFGS ANNALEN, no. 2, 1995, pages 267 - 277, XP000652072 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010030012A1 (ja) 2008-09-11 2010-03-18 独立行政法人理化学研究所 エステル化α－ガラクトシルセラミド類
US8580751B2 (en) 2008-09-11 2013-11-12 Riken Esterified α-galactosylceramide
EP2409966A1 (en) * 2009-03-20 2012-01-25 Consejo Superior de Investigaciones Científicas (CSIC) Aminocyclitol compounds, procedure for the obtainment and uses
CN102498090A (zh) * 2009-03-20 2012-06-13 康斯乔最高科学研究公司 氨基环醇化合物，获得它们的工艺以及用途
JP2012520857A (ja) * 2009-03-20 2012-09-10 コンセホ・スペリオール・デ・インベスティガシオネス・シエンティフィカス アミノシクリトール化合物、それらを得る方法およびその使用
EP2409966A4 (en) * 2009-03-20 2013-06-19 Consejo Superior Investigacion AMINOCYCLITOL COMPOUNDS, METHOD FOR THEIR OBTAINMENT AND USES THEREOF
US11744860B2 (en) 2016-04-28 2023-09-05 Riken Technology for efficient activation of NKT cells
WO2022102557A1 (ja) * 2020-11-12 2022-05-19 国立研究開発法人理化学研究所 擬似糖脂質誘導体並びにその合成中間体、製造方法及び用途

Also Published As

Publication number Publication date
US20100062990A1 (en) 2010-03-11
JP5504891B2 (ja) 2014-05-28
JPWO2008102888A1 (ja) 2010-05-27
EP2133326A4 (en) 2011-10-26
ES2561357T3 (es) 2016-02-25
US8299223B2 (en) 2012-10-30
EP2133326A1 (en) 2009-12-16
EP2133326B1 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
WO2006100082A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
WO2007025709A3 (en) Organic compounds
WO2008055870A8 (en) Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2008034859A8 (en) Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
WO2009024342A3 (en) Novel microbiocides
TW200740752A (en) 4-Biarylyl-1-phenylazetidin-2-ones
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
PL1758852T3 (pl) Podstawione związki cyklopentenu
PL1877367T3 (pl) Pochodne acetylenu
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
TW200702330A (en) 3,4,5-Substituted piperidines
DE602004024213D1 (en) Aminopropanolderivate
WO2008151828A3 (en) Novel microbiocides
WO2007117591A3 (en) Total synthesis of salinosporamide a and analogs thereof
TW200613270A (en) Ionic liquids having fluoroalkyltrifluoroborate anions
WO2008102888A1 (ja) 新規擬似糖脂質及びその用途
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
WO2005030794A3 (en) Hemiasterlin derivatives and uses thereof
SI1745010T1 (sl) Substituirani cikloheksil-1,4-diaminski derivati
WO2009003672A3 (en) Novel microbiocides
WO2007068473A3 (en) Organic compounds
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08711869

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009500256

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008711869

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12528232

Country of ref document: US